StockData
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (NAGE) stock

NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3013% below fair value
$2.01−0.06 (-2.66%)

Close on Nov 16, 2026Market cap $159.04MP/E 16.8Yield –

Niagen Bioscience gross margin

Gross margin is gross profit as a percentage of revenue.

Niagen Bioscience's gross margin for the twelve months ending Sep 30, 2026 was 63.9%. For fiscal 2025 it was 64.3%, against 61.8% the year before. The highest annual figure on record is 64.3% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202564.3%+2.4
FY2024Dec 31, 202461.8%+1.1
FY2023Dec 31, 202360.8%+1.4
FY2022Dec 31, 202259.4%−2.1
FY2021Dec 31, 202161.5%+2.0
FY2020Dec 31, 202059.5%+3.9
FY2019Dec 31, 201955.7%+4.8
FY2018Dec 31, 201850.9%+1.5
FY2017Dec 30, 201749.4%+1.5
FY2016Dec 31, 201648.0%+5.8
FY2015Jan 2, 201642.1%+7.4
FY2014Jan 3, 201534.8%+3.9
FY2013Dec 28, 201330.8%+11.2
FY2012Dec 29, 201219.6%−10.9
FY2011Dec 31, 201130.5%−8.5
FY2010Jan 1, 201138.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202662.9%−1.6
Q2 FY2026Jun 30, 202664.8%−0.2
Q1 FY2026Mar 31, 202663.5%+0.0
Q4 FY2025Dec 31, 202564.1%+1.7
Q3 FY2025Sep 30, 202564.5%+1.0
Q2 FY2025Jun 30, 202565.0%+4.8
Q1 FY2025Mar 31, 202563.4%+2.7
Q4 FY2024Dec 31, 202462.5%+1.4
Q3 FY2024Sep 30, 202463.5%+2.1
Q2 FY2024Jun 30, 202460.2%−0.6
Q1 FY2024Mar 31, 202460.7%+0.8
Q4 FY2023Dec 31, 202361.0%+3.8
Q3 FY2023Sep 30, 202361.4%+1.6
Q2 FY2023Jun 30, 202360.8%+0.8
Q1 FY2023Mar 31, 202359.9%−1.1
Q4 FY2022Dec 31, 202257.2%−4.0
Q3 FY2022Sep 30, 202259.8%−1.3
Q2 FY2022Jun 30, 202260.0%−1.1
Q1 FY2022Mar 31, 202261.0%−1.9
Q4 FY2021Dec 31, 202161.2%+0.2
Q3 FY2021Sep 30, 202161.1%+1.5
Q2 FY2021Jun 30, 202161.1%+1.6
Q1 FY2021Mar 31, 202162.9%+5.0
Q4 FY2020Dec 31, 202061.0%+4.0
Q3 FY2020Sep 30, 202059.6%+3.6
Q2 FY2020Jun 30, 202059.4%+3.1
Q1 FY2020Mar 31, 202057.9%+5.2
Q4 FY2019Dec 31, 201957.0%+5.1
Q3 FY2019Sep 30, 201956.0%+2.3
Q2 FY2019Jun 30, 201956.3%+7.0
Q1 FY2019Mar 31, 201952.8%+5.0
Q4 FY2018Dec 31, 201852.0%+1.0
Q3 FY2018Sep 30, 201853.7%+5.8
Q2 FY2018Jun 30, 201849.3%+4.1
Q1 FY2018Mar 31, 201847.8%+0.5
Q4 FY2017Dec 30, 201750.9%–
Q3 FY2017Sep 30, 201747.9%–
Q4 FY2016Dec 31, 201645.1%–
Q3 FY2016Oct 1, 201647.3%–

More Niagen Bioscience figures

See a number that looks wrong?